Latest Updates and Innovations: 
News & Videos

We keep you informed with the latest breakthroughs, updates, and stories from Cercare Medical. Dive into our articles to discover how we're pushing the boundaries of perfusion imaging, learn about our recent projects, and hear from the experts leading the way. Stay connected with the innovations and insights shaping the future of medical imaging.

Recent Posts

Basel, Switzerland

MAY 15th.-17th. , 2024
BOOTH N° B11

Leif Østergaard
Scientific board member

Cercare Medical at RSNA 2025!

07/10/2025
Cercare Medical at RSNA 2025!  Discover the Power of Advanced Perfusion Imaging  Perfusion imaging is transforming clinical practice…

Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows

06/02/2026
PRESS RELEASE Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows Latest release introduces AI-powered brain masking, improved PACS integration, and enhanced tumor and perfusion workflows. AARHUS, DENMARK, 6 February 2026: Cercare Medical, a leader in advanced neuroimaging software, today announces the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 18. The new […]
Read

Cercare Medical Showcases Breakthrough CBCT Perfusion Technology at RSNA 2025

28/11/2025
PRESS RELEASE Cercare Medical Showcases Breakthrough CBCT Perfusion Technology at RSNA 2025 Bringing Advanced Perfusion Imaging Into the Angio Suite to Transform Stroke and Oncology Care CHICAGO, IL, 28 Nov 2025: Cercare Medical will unveil its latest innovation - CBCT Perfusion - at RSNA 2025, held November 30 to December 4 at McCormick Place in Chicago. […]
Read

Cercare Medical Successfully Meets DTAC Requirements

24/11/2025
NEWS Cercare Medical Successfully Meets DTAC Requirements Cercare Medical is pleased to announce that our Cercare Medical Neurosuite platform has been independently assessed by a recognised 3rd party assessor to be fully compliant with the UK NHS Digital Technology Assessment Criteria (DTAC).The Digital Technology Assessment Criteria (DTAC) is the UK National Health Service’s standard for evaluating […]
Read

Cercare Medical Selected for Nationwide Hospital Rollout in Norway

24/06/2025
PRESS RELEASE Cercare Medical Selected for Nationwide Hospital Rollout in Norway Advanced Perfusion Imaging Software to Support Stroke and Oncology Diagnostics in Every Public Hospital. AARHUS, DENMARK, 23 June 2025: Cercare Medical is proud to announce its successful selection in the Norwegian National Tender for advanced imaging software. This award secures Cercare Medical’s installation across every […]
Read

Cercare Medical Secures Additional Regulatory Clearance in South Korea

06/06/2025
Cercare Medical Secures Additional Regulatory Clearance in South Korea Milestone approval and new partnership reinforce Cercare Medical’s strategic expansion across key Asian markets. AARHUS, DENMARK, 6 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is pleased to announce it has received additional regulatory clearance in South Korea for its Cercare Medical Neurosuite with […]
Read

Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging

04/06/2025
PRESS RELEASE Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging Latest update includes new, improved tools for more precise tumor assessment and stroke care. AARHUS, DENMARK, 4 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is proud to announce the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 17. […]
Read

Cercare Medical Secures FDA Clearance for CT Perfusion Imaging Software

12/12/2024
PRESS RELEASE Cercare Medical Secures FDA Clearance for CT Perfusion Imaging Software Milestone Achievement Expands Availability of Advanced Perfusion Imaging in Stroke Care. AARHUS, DENMARK, 12 Dec 2024: Cercare Medical is proud to announce FDA clearance for its CT perfusion imaging software, a significant milestone that complements the existing clearance for MRI perfusion imaging. This achievement underscores […]
Read

PRESS RELEASE: Groundbreaking Study Highlights Cercare Medical’s Role in Stroke Treatment Innovations

27/11/2024
PRESS RELEASE Groundbreaking Study Highlights Cercare Medical’s Role in Stroke Treatment Innovations Lyon Team's Study, Led by Dr. Bani-Sadr, Demonstrates How Advanced Biomarkers are Transforming Stroke Care. AARHUS, DENMARK, 27 Nov 2024: Cercare Medical proudly announces that a new study led by Dr. Alexandre Bani-Sadr and his team in Lyon, published on the front page of […]
Read

Cercare Medical at RSNA 2025!

07/10/2025
Cercare Medical at RSNA 2025!  Discover the Power of Advanced Perfusion Imaging  Perfusion imaging is transforming clinical practice…

Perfusion Summit 2026

12/08/2025
Summit/2603 Dinner/2603 Morning/2703 Afternoon/2703 Poster/2703 General Info Sign-Up Now! The 3rd Perfusion Summit Is ON — See You…

See you at ESOC 2025!

25/04/2025
See you at ESOC 2025! As part of our ongoing commitment to stay at the forefront of medical…

Cercare Medical at ECR 2025

03/02/2025
Cercare Medical at ECR 2025! Cercare Medical is proud to participate in ECR 2025, one of Europe’s largest…

Perfusion Summit 2025

06/11/2024
Perfusion Summit 2025 Main Event: Cercare Medical Perfusion Summit 2025 April 4, 2025 9:00 - 16:30 The Westin…

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
Contact us
Cercare Medical A/S
Inge Lehmanns Gade 10
8000 Aarhus C
Denmark

Solutions
Cercare Perfusion Neuro & Oncology Stroke Modules
Support
Assistance Instructions for Use
Company
Board Members Investors About News Career Privacy Policy Regulatory & Compliance
© 2026 Cercare Medical. All rights reserved.
TRY US

CLINICAL USE CASES AND TECHNICAL HIGHLIGHTS


CLINICAL USE CASES
  • Directly impacts the patient treatment pathway, both intra- and post-intervention.
  • Assess outcomes post-intervention: detect missed stenoses, distal occlusions, or microvascular disturbances.
  • Guide complementary therapies on the spot based on perfusion status.
  • May detect the no-reflow phenomenon — providing insight into cases where recovery may fail despite successful thrombectomy.
  • Potentially enables direct-to-angio workflows.

TECHNICAL HIGHLIGHTS
  • Full set of perfusion markers: CBF, CBV, MTT.
  • Advanced oxygen metabolism imaging: OEF, CMRO₂.
  • Most reliable results with 10 CBCT acquisitions.
  • Vendor-agnostic platform.

CBCT Imaging

Side-by-side comparison: The left-hand side is the raw CBCT data, while the right-hand side panel is the pre-processed data.
Using CMN software in the angio suite delivers results comparable to conventional CT/MR perfusion.

Explore CMN!

Fast. Reliable. Personalized.

Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.

Fill-out the form below, and a representative will contact you.

Thank you for uploading your DICOM files.

Your submission has been received successfully.

Next steps:

  • Our team will analyze the uploaded data.
  • A Cercare Medical representative will reach out to you once the analysis is complete.
  • Rest assured that all files will be deleted immediately after use, in line with our data protection policies.
Perfusion Summit 2026
Date: 26 March 2026, Thursday
Time: 10:15 - 17:15 (CET)
Venue: Concorde Hall, Hilton Paris Hotel, CDG
Participation is Optional

Hands-On Workshops
Date: 27 March 2026


Stroke Advanced and Oncology Advanced:

Seats are currently full. Registration is available as an Observer only.


CBCT Perfusion Workshop:

Due to overwhelming demand, registrations for this workshop will be placed on standby. We are actively exploring options to increase capacity.

Final confirmation for Observer and Standby participants will be communicated via email once a seat becomes available. We appreciate your understanding.
By participating in this event, you consent to the use of your image, voice, and likeness in photographs, and videos for promotional purposes, in accordance with GDPR regulations.

Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)

Imaging

MTT

SVD model

MTT

Vascular Model

T2 FLAIR

follow-up image
Perfusion maps of a stroke patient show a large difference in lesion appearance compared to the SVD technique, where the VM appears in better correspondence with the T2 FLAIR follow-up.

MTT

SVD model

MTT

Vascular Model

T2 FLAIR

follow-up image
The modest degree of tissue involvement is consistent with the
moderate neurologic deficits, National Institutes of Health Stroke
Scale (NIHSS) = 4.

Request a demo

Let us give you a tour around our solution.

Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.
})